Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 0 | 0 | 0 | 0 | 2,230 |
| Gross Profit | N/A | N/A | N/A | N/A | 2,230 |
| Operating Expenses | 34,690 | 30,104 | 45,915 | 12,596 | 7,017 |
| Operating Income | -34,690 | -30,104 | -45,915 | -12,596 | -4,787 |
| Other Income | 3,883 | 2,640 | 1,464 | 568 | 706 |
| Pre-tax Income | -30,807 | -27,464 | -44,451 | -12,028 | -4,081 |
| Income Tax | 1,106 | -108 | -642 | -4,414 | -1,571 |
| Net Income Continuous | -31,913 | -27,356 | -43,809 | -7,614 | -2,510 |
| Net Income Discontinuous | N/A | 154 | 2,048 | 80,050 | 8,119 |
| Net Income | $-31,913 | $-27,202 | $-41,761 | $72,436 | $5,609 |
| EPS Basic Total Ops | -780.00 | -720.00 | -1,160.00 | 2,200.00 | 170.00 |
| EPS Basic Continuous Ops | -782.87 | -719.29 | -1,220.00 | -230.00 | -80.00 |
| EPS Basic Discontinuous Ops | N/A | 4.05 | 60.00 | 2,430.00 | 250.00 |
| EPS Diluted Total Ops | -780.00 | -720.00 | -1,160.00 | 2,160.00 | 170.00 |
| EPS Diluted Continuous Ops | -782.87 | -719.29 | -1,220.00 | -230.00 | -80.00 |
| EPS Diluted Discontinuous Ops | N/A | 4.05 | 60.00 | 2,380.00 | 240.00 |
| EBITDA(a) | $-31,857 | $-29,712 | $-45,728 | $-11,991 | $-4,085 |